Başlık için Bildiri Koleksiyonu listeleme
Toplam kayıt 515, listelenen: 201-220
-
Feasibility investigation of prone position robotic radiosurgery treatment for dorsal metastasis
(Elsevier Ireland Ltd, 2017)The combination of Adaptive Radiotherapy (ART) and VMAT allows to create more conformal plans for patients with bladder cancer without risk of missing target during changes of bladder volume and shape. Relative position ... -
Feature-level fusion of physiological parameters to be used as cryptographic keys
(Institute of Electrical and Electronics Engineers Inc., 2017)In this paper, we propose two novel feature-level fused physiological parameter generation techniques: (i) concat-fused physiological parameter generation, and (ii) xor-fused physiological parameter generation, output of ... -
Frequency of undiagnosed atrial fibrillation in patients presenting with acute ischemic cerebrovascular stroke
(Oxford Univ Press, 2019)... -
A gender-based analysis of disease activity and its relationship with anxiety, depression, fatigue, and fibromyalgia in psoriatic arthritis
(Wiley, 2019)Background/Purpose: This study sought to compare the disease activity and its relationship with anxiety, depression, fatigue, and fibromyalgia of patients with psoriatic arthritis (PsA) between female and male gender in a ... -
The genetic profile of childhood neuromuscular disorders: A single center experience
(Pergamon-Elsevier Science Ltd., 2023)Neuromuscular Diseases are a heterogeneous group of childhood disorders, and differential diagnosis can be challenging. Although there is no definitive treatment for the most of this group of diseases, early diagnosis is ... -
Glass: Global lorlatinib for ALK(+) and ROS1(+) retrospective study: Real world data of 123 NSCLC patients
(Elsevier Science Inc, 2021)Introduction: Lorlatinib is a third-generation tyrosine-kinases inhibitor (TKI) targeting ALK/ROS1 fusions. The FDA has approved lorlatinib for TKI-pretreated ALK(+) NSCLC, while its approval for ROS1(+) is still pending. ... -
Glofitamab in relapsed/refractory diffuse large B cell lymphoma: Real world data
(American Society of Hematology, 2022)Abstract INTRODUCT ̇ION Glofitamab is a T-cell-engaging bispecific antibody connecting CD20 on B cells and CD3 on T cells. Although, most of the patients with B-cell non-Hodgkin lymphoma (BNHL) achieve complete response ... -
Graft-versus-host disease in a child with neuroblastoma after autologous bone marrow transplantation
(Nature Publishing Group, 2017)... -
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: A single center experience
(Nature Publishing Group, 2015)... -
HER2 expression and mismatch repair status in endometrial clear cell carcinoma
(Springer, 2022)... -
Hereditary spherocytosis associated with defects of human red blood cell membrane
(Wiley-Blackwell, 2015)...